StockWatch
·

Rhi Magnesita India Ltd Q1 FY27 Results

RHIMQ1 FY27 Results
Filing
Result:Very Good· Market: CrashedMargin expansionBroad based

Beat/Miss: Beat

MetricValueQ4 FY26Q1 FY26
Revenue1.0K Cr8.8%5.6%
Total Income1.0K Cr6.9%6.4%
Expenditure935.84 Cr3.5%2.5%
PBT87.41 Cr117.4%82.4%
Net Profit64.61 Cr112.5%83.2%
OPM13.58%63.87pp2.93pp
NPM6.31%60.44pp2.64pp
EPS3.1387.5%83.0%
View full financials

Revenue growth was modest but adjusted PAT jumped 83% YoY on genuine operating margin expansion (10.65%→13.58%), beating street expectations with no one-off gains distorting the comparison.

Q1 FY-2027 RESULTS · RHIM

RHI Magnesita Q1 FY27: consol PAT +83% YoY to ₹64.6 Cr, margin expands to 13.6%

PAT +83.19% YoY · revenue +5.59% · margins expanding · beat vs street

11 Aug 2026 · 3 min read
Revenue

₹1,013.97 Cr

+5.59% YoY

PAT (consolidated)

₹64.61 Cr

+83.19% YoY

Net margin

6.31%

+2.6pp YoY

EPS

₹3.13

RHI Magnesita India's consolidated revenue rose 5.6% YoY to ₹1,013.97 Cr (+8.8% QoQ) in Q1 FY27 (quarter ended June 30, 2026), while consolidated net profit jumped 83.2% YoY to ₹64.61 Cr from ₹35.27 Cr a year ago — both figures clean of one-off items on either side of the comparison, so the growth is organic. Standalone PAT grew a slower 68.0% YoY to ₹78.19 Cr on 7.2% revenue growth to ₹863.45 Cr; the wider consolidated gain implies the group's subsidiaries, including RHI Magnesita India Refractories Ltd (RHIMIRL, whose carrying value was written down at the standalone level last quarter), contributed disproportionately to the improvement — Intermetal Engineers and Ashwath Technologies alone added ₹6.78 Cr revenue and ₹1.03 Cr PAT to the consolidated numbers this quarter.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹1,013.97 Cr+8.8%+5.6%
Expenses₹935.84 Cr+3.5%+2.4%
PAT₹64.61 Cr+83.19%
Net margin6.31%+60.4pp+2.6pp
EPS₹3.13-87.5%+83%

The operating margin (EBITDA excluding other income) expanded to roughly 13.6% of revenue from 10.65% a year ago, and net margin rose to 6.37% from 3.67%. Sequentially the quarter is a clean bounce-back from Q4 FY26's reported net loss, but that loss was entirely a function of the ~Rs.556 Cr consolidated goodwill impairment taken against RHIMIRL and is not a like-for-like base; on an adjusted basis Nuvama had pegged Q4 FY26 adjusted EBITDA margin at 12.1% (against its own estimate of a higher print), so this quarter's ~13.6% still marks genuine sequential margin improvement, consistent with price hikes flowing through.

335.21359.6384408.4432.79415.5505-0806-0106-2307-1608-0708-11Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹415.55, up 0.6% over the past month of trading.

₹ Cr
-588.03-347.18-106.32134.5436.18Q4 FY25rev ₹918 Cr35.27Q1 FY26rev ₹960 Cr38.35Q2 FY26rev ₹1,035 Cr61.56Q3 FY26rev ₹1,092 Cr-518.11Q4 FY26rev ₹932 Cr64.61Q1 FY27rev ₹1,014 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records.

What management guided (3 FY-2026 call)
Management guides for Q4 margins to be similar to or slightly better than Q3's 13.7%, supported by a sustainable realization rate and a robust order book, though they remain cautious due to market headwinds. The long-term strategy focuses on expanding their high-value 4PRO solutions, which are expected to grow 4-5% nex

On the street side, no discrete Q1 FY27 PAT estimate was found, but Nuvama's post-Q4 note explicitly expected margin recovery in Q1 FY27 on price hikes and a robust order book, modelling 13%/13.5% EBITDA margins for FY27E/28E — the actual ~13.6% op margin already clears that full-year bar in the first quarter, a beat on trajectory even without a hard PAT comparison. Management gives no formal quarter-specific guidance on record for Q1 FY27 itself; the only prior guidance in our records (from the Q3 FY26 call) targeted Q4 FY26 margins near 13.7%, a bar that quarter missed on an adjusted basis (~12.1%), so this print is a partial recovery toward, not a return to, that earlier level. No press release commentary was available for this filing, so framing rests on the reported figures alone.

  • W1

    Whether consolidated operating margin holds near/above the ~13% FY27E level Nuvama models, given price hikes are the stated driver

  • W2

    Clarity on the incoming statutory auditor following Price Waterhouse's resignation effective August 14, 2026

  • W3

    First financial contribution of the new RHI Khemka Minpro JV (51% stake) in coming quarters

Converted from Rs. Lakhs (source unit) to Rs. Crore by /100; both statement tables tie exactly to reported totals. Neither the current quarter nor the year-ago quarter carries an exceptional item, so raw and adjusted YoY growth are identical (no adjustment needed). The immediately prior quarter (Q4 FY26) carried a one-off goodwill/investment impairment (~Rs.556 Cr consolidated, ~Rs.661 Cr standalone) that pushed it to a net loss, so patQoQPct is left null as not meaningful.

Informational and educational content only. Not investment advice.

Rhi Magnesita India Ltd (RHIM) Q1 FY27 Results — StockWatch